SCHEMBL4229018

SCHEMBL4229018

O=c1c2sccc2nc(CCCNc2nc(F)nc3c2ncn3C2CCCCO2)n1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ YTHDC1 Q96MU7 1/20 0.38
▸ FLT3 P36888 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PIK3CD O00329 2/20 0.35
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ CDK1 P06493 2/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4228491 0.92 NPC1 (0.53) SMN1; SMN2NPC1RAB9AYTHDC1ALDH1A1
SCHEMBL4227286 0.85 NPC1 (0.46) SMN1; SMN2NPC1RAB9AYTHDC1FLT3
SCHEMBL4227217 0.85 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AYTHDC1FLT3
SCHEMBL4237005 0.84 NPC1 (0.46) SMN1; SMN2NPC1RAB9AYTHDC1FLT3
SCHEMBL4233647 0.83 NPC1 (0.45) SMN1; SMN2NPC1RAB9AYTHDC1ADORA1
SCHEMBL4237270 0.82 PIK3CD (0.49) SMN1; SMN2NPC1RAB9AYTHDC1FLT3
SCHEMBL1703502 0.81 PIK3CD (0.42) SMN1; SMN2NPC1RAB9AYTHDC1FLT3
SCHEMBL12471910 0.76 NPC1 (0.55) SMN1; SMN2NPC1RAB9AYTHDC1ALDH1A1
SCHEMBL4236551 0.76 PIK3CD (0.43) SMN1; SMN2RAB9AALDH1A1TSHRPIK3CD
SCHEMBL1703383 0.74 NPC1 (0.49) SMN1; SMN2NPC1RAB9APIK3CDPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097422-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS Eli Lilly & Co. (US) 2009-09-09 — — EP disclosed
WO-2008064018-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS ELI LILLY & CO. (US) 2008-05-29 — — WO disclosed
Send feedback